|
C12ORF65 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.335000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.359800E-01 |
| Normal-vs-Stage2 |
9.623800E-01 |
| Normal-vs-Stage3 |
7.492000E-02 |
| Normal-vs-Stage4 |
3.746000E-01 |
| Stage1-vs-Stage2 |
7.714600E-01 |
| Stage1-vs-Stage3 |
8.127700E-02 |
| Stage1-vs-Stage4 |
5.200400E-01 |
| Stage2-vs-Stage3 |
1.907610E-01 |
| Stage2-vs-Stage4 |
5.158400E-01 |
| Stage3-vs-Stage4 |
5.636000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.565200E-01 |
| Normal-vs-AfricanAmerican |
1.410420E-01 |
| Normal-vs-Asian |
3.845600E-01 |
| Caucasian-vs-AfricanAmerican |
2.151400E-01 |
| Caucasian-vs-Asian |
4.944000E-02 |
| AfricanAmerican-vs-Asian |
5.024100E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.294600E-01 |
| Normal-vs-Female |
2.327800E-01 |
| Male-vs-Female |
2.816800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.717600E-01 |
| Normal-vs-Age(41-60Yrs) |
6.396400E-01 |
| Normal-vs-Age(61-80Yrs) |
5.169800E-02 |
| Normal-vs-Age(81-100Yrs) |
2.913600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.490800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.900200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.802200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.674200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.684400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.842200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.123840E-01 |
| Classical-VS-Follicular |
6.135400E-01 |
| Classical-VS-Other |
5.617000E-01 |
| Classical-VS-Normal |
5.919600E-01 |
| Tall-VS-Follicular |
8.820400E-02 |
| Tall-VS-Other |
1.870570E-01 |
| Tall-VS-Normal |
6.737700E-02 |
| Follicular-VS-Other |
8.012600E-01 |
| Follicular-VS-Normal |
9.960800E-01 |
| Other-VS-Normal |
7.135200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.350400E-01 |
| Normal-vs-N1 |
5.378400E-01 |
| N0-vs-N1 |
7.947000E-01 |
|
|
